Regularities of Encapsulation of Tolfenamic Acid and Some Other Non-Steroidal Anti-Inflammatory Drugs in Metal-Organic Framework Based on γ-Cyclodextrin

Metal-organic frameworks based on cyclodextrins (CDs) have been proposed as promising drug delivery systems due to their large surface area, variable pore size, and biocompatibility. In the current work, we investigated an incorporation of tolfenamic acid (TA), a representative of non-steroidal anti-inflammatory drugs (NSAIDs), in a metal-organic framework based on gamma-cyclodextrin and potassium cations (gamma CD-MOF). Composites gamma CD-MOF/TA obtained by absorption and co-crystallization methods were characterized using powder X-ray diffraction, low temperature nitrogen adsorption/desorption, scanning electron microscopy, and FTIR spectroscopy. It was demonstrated that TA loaded in gamma CD-MOF has an improved dissolution profile. However, the inclusion of TA in gamma-CD reduces the membrane permeability of the drug. A comparative analysis of the encapsulation of different NSAIDs in gamma CD-MOF was performed. The impact of NSAID structure on the loading capacity was considered for the first time. It was revealed that the presence of heterocycles in the structure and drug lipophilicity influence the loading efficiency of NSAIDs in gamma CD-MOF.

Automated summary

Metal-organic frameworks based on cyclodextrins have potential as drug delivery systems due to their properties such as large surface area, variable pore size, and biocompatibility. In this study, the incorporation of tolfenamic acid in a metal-organic framework based on gamma-cyclodextrin and potassium cations was investigated. The inclusion of tolfenamic acid improved its dissolution profile but reduced its membrane permeability. The encapsulation of different NSAIDs in this metal-organic framework was also compared, considering the impact of NSAID structure on loading capacity.